On September 15, the Veterans’ Prostate Cancer Treatment and Research Act was introduced in the Senate (S. 2720) by Senators Jerry Moran (R-KS) and Jon Tester (D-MT) – Ranking Member and Chairman of the Senate Veterans’ Affairs Committee, respectively. For the first time, this bill is now in both chambers of Congress, which is a critical step in the legislative process. As mentioned in previous updates, the House version of the VA bill was introduced in the U.S. House of Representatives (H.R. 4880) earlier this year. This legislation directs the Secretary of Veterans Affairs to establish a national clinical pathway for prostate cancer within the National Surgery Office of the Veterans Administration for all stages of prostate cancer.
Since 2019, the AUA has been working closely with other urologic stakeholders to move this legislation through the legislative process. It passed the House in September 2020 but failed to move in the Senate, so the bill required reintroduction this year. Representative and urologist Neal Dunn, MD (R-FL-02) is the bill's primary sponsor. Original cosponsors include the other urologist serving in Congress, Rep. Greg Murphy (R-NC-03), as well as Rep. Elissa Slotkin (D-MI-08), and Rep. Colin Allred (D-TX-32).
Please contact your legislators in the House and Senate and urge them to cosponsor H.R. 4880/S. 2720 today!